Working… Menu

Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible (TCP-AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02261779
Recruitment Status : Unknown
Verified July 2015 by Dr. Petra Tschanter, Martin-Luther-Universität Halle-Wittenberg.
Recruitment status was:  Recruiting
First Posted : October 10, 2014
Last Update Posted : July 7, 2015
Information provided by (Responsible Party):
Dr. Petra Tschanter, Martin-Luther-Universität Halle-Wittenberg

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2017
Estimated Study Completion Date : September 2017